{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:41:13Z","timestamp":1773844873161,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,28]]},"DOI":"10.7759\/cureus.35601","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T19:31:32Z","timestamp":1677612692000},"source":"Crossref","is-referenced-by-count":2,"title":["Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins"],"prefix":"10.7759","author":[{"given":"Bahaa O","family":"Sahib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim H","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassar T","family":"Alibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas A","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2017.10.011","article-title":"Hypogonadism: therapeutic risks, benefits, and outcomes","volume":"102","author":"Sigalos JT","year":"2018","unstructured":"Sigalos JT, Pastuszak AW, Khera M. Hypogonadism: therapeutic risks, benefits, and outcomes. Med Clin North Am. 2018, 102:361-72. 10.1016\/j.mcna.2017.10.011","journal-title":"Med Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-1016","article-title":"Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study","volume":"73","author":"Gray A","year":"1991","unstructured":"Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991, 73:1016-25. 10.1210\/jcem-73-5-1016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0313-8","article-title":"Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis","volume":"18","author":"Gao Y","year":"2018","unstructured":"Gao Y, Yu B, Mao J, Wang X, Nie M, Wu X. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis. BMC Endocr Disord. 2018, 18:85. 10.1186\/s12902-018-0313-8","journal-title":"BMC Endocr Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.112","article-title":"Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment","volume":"11","author":"Boehm U","year":"2015","unstructured":"Boehm U, Bouloux PM, Dattani MT, et al.. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015, 11:547-64. 10.1038\/nrendo.2015.112","journal-title":"Nat Rev Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2013.08.006","article-title":"The epidemiology of male infertility","volume":"41","author":"Winters BR","year":"2014","unstructured":"Winters BR, Walsh TJ. The epidemiology of male infertility. Urol Clin North Am. 2014, 41:195-204. 10.1016\/j.ucl.2013.08.006","journal-title":"Urol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.760","article-title":"Current national and international guidelines for the management of male hypogonadism: helping clinicians to navigate variation in diagnostic criteria and treatment recommendations","volume":"35","author":"Al-Sharefi A","year":"2020","unstructured":"Al-Sharefi A, Quinton R. Current national and international guidelines for the management of male hypogonadism: helping clinicians to navigate variation in diagnostic criteria and treatment recommendations. Endocrinol Metab (Seoul). 2020, 35:526-40. 10.3803\/EnM.2020.760","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-41","article-title":"Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland","volume":"6","author":"Laitinen EM","year":"2011","unstructured":"Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, Raivio T. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis. 2011, 6:41. 10.1186\/1750-1172-6-41","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03746.x","article-title":"What is the optimal therapy for young males with hypogonadotropic hypogonadism?","volume":"72","author":"Han TS","year":"2010","unstructured":"Han TS, Bouloux PM. What is the optimal therapy for young males with hypogonadotropic hypogonadism?. Clin Endocrinol (Oxf). 2010, 72:731-7. 10.1111\/j.1365-2265.2009.03746.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020518","article-title":"Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism","volume":"87","author":"Pitteloud N","year":"2002","unstructured":"Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002, 87:4128-36. 10.1210\/jc.2002-020518","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2022.2084690","article-title":"What are the pharmacological considerations for male congenital hypogonadotropic hypogonadism?","volume":"23","author":"Rastrelli G","year":"2022","unstructured":"Rastrelli G, Maggi M, Corona G. What are the pharmacological considerations for male congenital hypogonadotropic hypogonadism?. Expert Opin Pharmacother. 2022, 23:1009-13. 10.1080\/14656566.2022.2084690","journal-title":"Expert Opin Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.173938","article-title":"Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use","volume":"18","author":"McBride JA","year":"2016","unstructured":"McBride JA, Coward RM. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl. 2016, 18:373-80. 10.4103\/1008-682X.173938","journal-title":"Asian J Androl"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_6_19","article-title":"Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism","volume":"21","author":"Ortac M","year":"2019","unstructured":"Ortac M, Hidir M, Salabas E, Boyuk A, Bese C, Pazir Y, Kadioglu A. Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism. Asian J Androl. 2019, 21:623-7. 10.4103\/aja.aja_6_19","journal-title":"Asian J Androl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390298","article-title":"Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases","volume":"139","author":"B\u00fcchter D","year":"1998","unstructured":"B\u00fcchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998, 139:298-303. 10.1530\/eje.0.1390298","journal-title":"Eur J Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_88_19","article-title":"Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients","volume":"22","author":"Hao M","year":"2020","unstructured":"Hao M, Nie M, Yu BQ, et al.. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients. Asian J Androl. 2020, 22:390-5. 10.4103\/aja.aja_88_19","journal-title":"Asian J Androl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1664","article-title":"Approach to the male patient with congenital hypogonadotropic hypogonadism","volume":"97","author":"Young J","year":"2012","unstructured":"Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012, 97:707-18. 10.1210\/jc.2011-1664","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","article-title":"Gonadotropin treatment of hypogonadotropic hypogonadal adolescents","volume":"12 Suppl 1","author":"Bouvattier C","year":"1999","unstructured":"Bouvattier C, Tauber M, Jouret B, Chaussain J L, Rochiccioli P. Gonadotropin treatment of hypogonadotropic hypogonadal adolescents. J Pediatr Endocrinol Metabol. 1999, 12 Suppl 1:339-44.","journal-title":"J Pediatr Endocrinol Metabol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(98)00450-6","article-title":"Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism","volume":"71","author":"Barrio R","year":"1999","unstructured":"Barrio R, de Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril. 1999, 71:244-8. 10.1016\/s0015-0282(98)00450-6","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12435","article-title":"Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism","volume":"81","author":"Shiraishi K","year":"2014","unstructured":"Shiraishi K, Oka S, Matsuyama H. Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf). 2014, 81:259-65. 10.1111\/cen.12435","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-6-1144","article-title":"Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size","volume":"66","author":"Burris AS","year":"1988","unstructured":"Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab. 1988, 66:1144-51. 10.1210\/jcem-66-6-1144","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198509123131102","article-title":"Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism","volume":"313","author":"Finkel DM","year":"1985","unstructured":"Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985, 313:651-5. 10.1056\/NEJM198509123131102","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1992.tb01131.x","article-title":"Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up","volume":"15","author":"Vicari E","year":"1992","unstructured":"Vicari E, Mongio\u00ec A, Calogero AE, Moncada ML, Sidoti G, Polosa P, D'Agata R. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up. Int J Androl. 1992, 15:320-9. 10.1111\/j.1365-2605.1992.tb01131.x","journal-title":"Int J Androl"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1994.tb01249.x","article-title":"Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism","volume":"17","author":"Kung AW","year":"1994","unstructured":"Kung AW, Zhong YY, Lam KS, Wang C. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. Int J Androl. 1994, 17:241-7. 10.1111\/j.1365-2605.1994.tb01249.x","journal-title":"Int J Androl"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2014.10.005","article-title":"Gonadotrophin replacement for induction of fertility in hypogonadal men","volume":"29","author":"Dwyer AA","year":"2015","unstructured":"Dwyer AA, Raivio T, Pitteloud N. Gonadotrophin replacement for induction of fertility in hypogonadal men. Best Pract Res Clin Endocrinol Metab. 2015, 29:91-103. 10.1016\/j.beem.2014.10.005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(sup01)09","article-title":"Hypogonadotropic hypogonadism revisited","volume":"68 Suppl 1","author":"Fraietta R","year":"2013","unstructured":"Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo). 2013, 68 Suppl 1:81-8. 10.6061\/clinics\/2013(sup01)09","journal-title":"Clinics (Sao Paulo)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0203-1","article-title":"Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism","volume":"13","author":"Farhat R","year":"2010","unstructured":"Farhat R, Al-zidjali F, Alzahrani AS. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary. 2010, 13:105-10. 10.1007\/s11102-009-0203-1","journal-title":"Pituitary"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.01.011","article-title":"Correlations among genotype and outcome in Chinese male patients with congenital hypogonadotropic hypogonadism under hCG treatment","volume":"17","author":"Chen Y","year":"2020","unstructured":"Chen Y, Sun T, Niu Y, et al.. Correlations among genotype and outcome in Chinese male patients with congenital hypogonadotropic hypogonadism under hCG treatment. J Sex Med. 2020, 17:645-57. 10.1016\/j.jsxm.2020.01.011","journal-title":"J Sex Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-0065-0","article-title":"Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience","volume":"44","author":"Yang L","year":"2012","unstructured":"Yang L, Zhang SX, Dong Q, Xiong ZB, Li X. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol. 2012, 44:393-9. 10.1007\/s11255-011-0065-0","journal-title":"Int Urol Nephrol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-1-3","article-title":"Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men","volume":"70","author":"Whitcomb RW","year":"1990","unstructured":"Whitcomb RW, Crowley WF Jr. Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J Clin Endocrinol Metab. 1990, 70:3-7. 10.1210\/jcem-70-1-3","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s43043-022-00099-2","article-title":"Obesity and male infertility: multifaceted reproductive disruption","volume":"27","author":"Chaudhuri GR","year":"2022","unstructured":"Chaudhuri GR, Das A, Kesh SB, Bhattacharya K, Dutta S, Sengupta P, Syamal AK. Obesity and male infertility: multifaceted reproductive disruption. Middle East Fertility Soc J. 2022, 27:8. 10.1186\/s43043-022-00099-2","journal-title":"Middle East Fertility Soc J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000100874","article-title":"Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy","volume":"68","author":"Hadziselimovic F","year":"2007","unstructured":"Hadziselimovic F, Hocht B, Herzog B, Buser MW. Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res. 2007, 68:46-52. 10.1159\/000100874","journal-title":"Horm Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135431-management-outcomes-in-males-with-hypogonadotropic-hypogonadism-treated-with-gonadotropins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:26Z","timestamp":1707508466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135431-management-outcomes-in-males-with-hypogonadotropic-hypogonadism-treated-with-gonadotropins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.35601","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}